✦ LIBER ✦

Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer

✍ Scribed by Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of gefitinib (‘Iressa’, ZD1839) o

✍ Hotta, Katsuyuki; Kiura, Katsuyuki; Ueoka, Hiroshi; Tabata, Masahiro; Fujiwara, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Outcomes of patients with advanced non-s

✍ Jänne, Pasi A.; Gurubhagavatula, Sarada; Yeap, Beow Y.; Lucca, Joan; Ostler, Pat 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB

P-620 Gefitinib (‘Iressa’, ZD1839) monot

✍ Park, Jinny; Park, Byeong-Bae; Lee, Se-Hoon; Park, Se Hoon; Lee, Kyung-Eun; Lee, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

P-617 Gefitinib (ZD 1839, Iressa) as a l

✍ Haringhuizen, Annebeth; Vaessen, Heleen F.R.; Baas, Paul; van Zandwijk, Nico 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

O-243 Clinical benefits in patients with

✍ Janne, Pasi A.; Gurubhagavatula, Sarada; Lucca, Joan; Ostler, Patricia; Skarin, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

New hope for patients with non-small-cel

✍ Glenwood Goss 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 43 KB